1009 Results

People

  1. Motzer
    Motzer
  2. O'Reilly
    O'Reilly
  3. Kris
    Kris
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Bajorin
    Bajorin
  7. Kelsen
    Kelsen
  8. Ginsberg
    Ginsberg
  9. Krug
    Krug
  10. Scher
    Scher

Groups

  1. Department of Medicine (716)
  2. Solid Tumor Oncology Division (483)
  3. Hematologic Malignancies, Division of (277)
  4. Center for Hematologic Malignancies (224)
  5. Survivorship Research (151)
  6. Genitourinary Oncology Service (136)
  7. Epidemiology and Biostatistics (119)
  8. Radiology, Department of (111)
  9. Biostatistics Service (109)
  10. GSK Faculty (104)
  1. "anemia"
Formats
  1. Journal Article (926)
  2. Review (42)
  3. Research Letter (15)
  4. Conference Paper (12)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (3)
  8. Correspondence (2)
  9. Book Section (1)
  10. Meeting Abstract (1)
Groups
  1. Department of Medicine (716)
  2. Solid Tumor Oncology Division (483)
  3. Hematologic Malignancies, Division of (277)
  4. Center for Hematologic Malignancies (224)
  5. Survivorship Research (151)
  6. Genitourinary Oncology Service (136)

More Groups

People
  1. Robert Motzer (55)
  2. Eileen O'Reilly (35)
  3. Mark Kris (32)
  4. Carol Aghajanian (31)
  5. Clifford Hudis (31)
  6. Dean Bajorin (29)

More People

Years
  1. 2025 (41)
  2. 2024 (99)
  3. 2023 (56)
  4. 2022 (45)
  5. 2021 (25)
  6. 2020 (62)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer (50)
  3. Clinical Cancer Research (49)
  4. Lancet Oncology (47)
  5. Gynecologic Oncology (34)
  6. Blood (29)

More Publications

Publishers
  1. Elsevier Inc. (147)
  2. Springer (90)
  3. Elsevier Science, Inc. (83)
  4. American Society of Clinical Oncology (74)
  5. Wiley Blackwell (65)
  6. Nature Publishing Group (61)

More Publishers

Results (1009)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
    Journal Article

    Brahmer, J. R.; Long, G. V.; Hamid, O.; Garon, E. B.; Herbst, R. S.; Andre, T.; Armand, P.; Bajorin, D.; Bellmunt, J.; Burtness, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Radiosensitizing favors response to peptide receptor radionuclide therapy in patients with highly proliferative neuroendocrine malignancies: Preliminary evidence from a clinical pilot study
    Journal Article

    Trautwein, N. F.; Hinterleitner, C.; Kiefer, L. S.; Singer, S.; Mattern, S.; Schwenck, J.; Reischl, G.; Sipos, B.; Lauer, U. M.; Dittmann, H.; more...
    Clinical Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Development of a practical nomogram for personalized anemia management in patients treated with ataxia telangiectasia and Rad3-related inhibitor camonsertib
    Journal Article

    Rosen, E.; Yap, T. A.; Lee, E. K.; Højgaard, M.; Mettu, N. B.; Lheureux, S.; Carneiro, B. A.; Plummer, R.; Fretland, A. J.; Ulanet, D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
    Journal Article

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. Y.; Mohan, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Sharon, E.; Park, S.; Ramaswamy, R.; Roe, C. E.; Irish, J. M.; Caldwell, A.; Wei, W.; Yacoub, A.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer
    Journal Article

    Boerner, T.; Lam, C.; Basaran, D.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Long Roche, K.; Zivanovic, O.; Abu-Rustum, N. R.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
    Journal Article

    Lin, C. C.; Garralda, E.; Schöffski, P.; Hong, D. S.; Siu, L. L.; Martin, M.; Maur, M.; Hui, R.; Soo, R. A.; Chiu, J.; more...
    OncoImmunology (2024)

    Fulltext@MSK | Save
  • Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Camidge, D. R.; Lin, J. J.; Kim, S. W.; Solomon, B. J.; Dziadziuszko, R.; Besse, B.; Goto, K.; de Langen, A. J.; Wolf, J.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Oncology for the rhinologist
    Review

    Tam, K.; Dunn, L. A.; Cohen, M. A.
    Current Opinion in Otolaryngology & Head and Neck Surgery (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save